|
1
|
Robbins KT, Storniolo AM, Kerber C,
Seagren S, Berson A and Howell SB: Rapid superselective high-dose
cisplatin infusion for advanced head and neck malignancies. Head
Neck. 14:364–371. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Robbins KT, Kumar P, Wong FS, Hartsell WF,
Flick P, Palmer R, Weir AB III, Neill HB, Murry T, Ferguson R, et
al: Targeted chemoradiation for advanced head and neck cancer:
Analysis of 213 patients. Head Neck. 22:687–693. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kobayashi W, Teh BG, Narita N, Ito R,
Saito Y, Furudate K, Kimura H, Kakehata S and Kawaguchi H:
Comparative study of superselective intra-arterial
chemoradiotherapy versus radical surgery on distant metastasis for
advanced oral cancer. J Oral Oncol. 2014:1927342014.
|
|
4
|
Myerson RJ, Outlaw ED, Chang A, Birnbaum
EH, Fleshman JW, Grigsby PW, Kodner IJ, Malayapa RS, Mutch MG,
Parikh P, et al: Radiotherapy for epidermoid carcinoma of the anus:
Thirty year' experience. Int J Radiat Oncol Biol Phys. 75:428–435.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Das P, Bhatia S, Eng C, Ajani JA, Skibber
JM, Rodriguez-Bigas MA, Chang GJ, Bhosale P, Delclos ME, Krishnan
S, et al: Predictors and patterns of recurrence after definitive
chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys.
68:794–800. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wright JL, Patil SM, Temple LK, Minsky BD,
Saltz LB and Goodman KA: Squamous cell carcinoma of the anal canal:
Patterns and predictors of failure and implications for
intensity-modulated radiation treatment planning. Int J Radiat
Oncol Biol Phys. 78:1064–1072. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Salesiotis AN and Cullen KJ: Molecular
markers predictive of response and prognosis in the patient with
advanced squamous cell carcinoma of the head and neck: Evolution of
a model beyond TNM staging. Curr Opin Oncol. 12:29–39. 2000.
View Article : Google Scholar
|
|
8
|
Zhang Y, He W and Zhang S: Seeking for
correlative genes and signaling pathways with bone metastasis from
breast cancer by integrated analysis. Front Oncol. 9:1382019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
La TH, Filion EJ, Turnbull BB, Chu JN, Lee
P, Nguyen K, Maxim P, Quon A, Graves EE, Loo BW Jr and Le QT:
Metabolic tumor volume predicts for recurrence and death in
head-and-neck cancer. Int J Radiat Oncol Biol Phys. 74:1335–1341.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Murphy JD, La TH, Chu K, Quon A, Fischbein
NJ, Maxim PG, Graves EE, Loo BW Jr and Le QT: Postradiation
metabolic tumor volume predicts outcome in head-and-neck cancer.
Int J Radiat Oncol Biol Phys. 80:514–521. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shimizu M, Mitsudo K, Koike I, Taguri M,
Iwai T, Koizumi T, Oguri S, Kioi M, Hirota M, Inoue T and Tohnai I:
Prognostic value of 2-[(18) F]fluoro-2-deoxy-D-glucose positron
emission tomography for patients with oral squamous cell carcinoma
treated with retrograde superselective intra-arterial chemotherapy
and daily concurrent radiotherapy. Oral Surg Oral Med Oral Pathol
Oral Radiol. 121:239–247. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kobayashi W, Teh BG, Sakaki H, Sato H,
Kimura H, Kakehata S and Nagahata M: Superselective intra-arterial
chemoradiotherapy with docetaxel-nedaplatin for advanced oral
cancer. Oral Oncol. 46:860–863. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Keramida G, Potts J, Bush J, Dizdarevic S
and Peters AM: Hepatic steatosis is associated with increased
hepatic FDG uptake. Eur J Radiol. 83:751–755. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kobayashi W, Kukobota K, Ito R, Sakaki H,
Nakagawa H and Teh BG: Can superselective intra-arterial
chemoradiotherapy replace surgery followed by radiation for
advanced cancer of the tongue and floor of the mouth? J Oral
Maxillofac Surg. 74:1248–1254. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Minn H, Lapela M, Klemi PJ, Grénman R,
Leskinen S, Lindholm P, Bergman J, Eronen E, Haaparanta M and
Joensuu H: Prediction of survival with
fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J
Nucl Med. 38:1907–1911. 1997.PubMed/NCBI
|
|
17
|
Koyasu S, Nakamoto Y, Kikuchi M, Suzuki K,
Hayashida K, Itoh K and Togashi K: Prognostic value of pretreatment
18F-FDG PET/CT parameters including visual evaluation in patients
with head and neck squamous cell carcinoma. AJR Am J Roentgenol.
202:851–858. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brun E, Kjellén E, Tennvall J, Ohlsson T,
Sandell A, Perfekt R, Perfekt R, Wennerberg J and Strand SE: FDG
PET studies during treatment: prediction of therapy outcome in head
and neck squamous cell carcinoma. Head Neck. 24:127–135. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schwartz DL, Rajendran J, Yueh B, Coltrera
MD, Leblanc M, Eary J and Krohn K: FDG-PET prediction of head and
neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck
Surg. 130:1361–1367. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Machtay M, Natwa M, Andrel J, Hyslop T,
Anne PR, Lavarino J, Intenzo CM and Keane W: Pretreatment FDG-PET
standardized uptake value as a prognostic factor for outcome in
head and neck cancer. Head Neck. 31:195–201. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Halfpenny W, Hain SF, Biassoni L, Maisey
MN, Sherman JA and McGurk M: FDG-PET. A possible prognostic factor
in head and neck cancer. Br J Cancer. 86:512–516. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Torizuka T, Kanno T, Futatsubashi M,
Naitou K, Ueda Y and Ouchi Y: Prognostic value of 18F-FDG PET in
patients with head and neck squamous cell cancer. AJR Am J
Roentgenol. 192:156–160. 2009. View Article : Google Scholar
|
|
23
|
Allal AS, Slosman DO, Kebdani T, Allaoua
M, Lehmann W and Dulguerov P: Prediction of outcome in
head-and-neck cancer patients using the standardized uptake value
of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys.
59:1295–1300. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Allal AS, Dulguerov P, Allaoua M,
Haenggeli CA, El-Ghazi el A, Lehmann W and Slosman DO: Standardized
uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting
outcome in head and neck carcinomas treated by radiotherapy with or
without chemotherapy. J Clin Oncol. 20:1398–1404. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Roh JL, Pae KH, Choi SH, Kim JS, Lee S,
Kim SB, Nam SY and Kim SY: 2-[18F]-Fluoro-2-deoxy-D-glucose
positron emission tomography as guidance for primary treatment in
patients with advanced-stage resectable squamous cell carcinoma of
the larynx and hypopharynx. Eur J Surg Oncol. 33:790–795. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Morikawa T, Futoo E, Bessho H, Yakushiji
T, Nomura T, Onodera S, Uchino Y, Takano N, Shibahara T and
Katakura A: 18F-FDG PET/CT parameters as imaging biomarker is
useful in oral squamous cell carcinoma patients. Jpn J Soc Oral
Oncol. 29:23–35. 2017. View Article : Google Scholar
|
|
27
|
Patronas NJ, Di Chiro G, Kufta C,
Bairamian D, Kornblith PL, Simon R and Larson SM: Prediction of
survival in glioma patients by means of positron emission
tomography. J Neurosurg. 62:816–822. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Okada J, Yoshikawa K, Itami M, Imaseki K,
Uno K, Itami J, Kuyama J, Mikata A and Arimizu N: Positron emission
tomography using fluorine-18-fluorodeoxyglucose in malignant
lymphoma: A comparison with proliferative activity. J Nucl Med.
33:325–329. 1992.PubMed/NCBI
|
|
29
|
Ahuja V, Coleman RE, Herndon J and Patz EF
Jr: The prognostic significance of fluorodeoxyglucose positron
emission tomography imaging for patients with nonsmall cell lung
carcinoma. Cancer. 83:918–924. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cardenas ML, Spencer CR, Markovina S,
DeWees TA, Mazur TR, Weiner AA, Parikh PJ and Olsen JR:
Quantitative FDG-PET/CT predicts local recurrence and survival for
squamous cell carcinoma of the anus. Adv Radiat Oncol. 2:281–287.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Suzuki-Shibata S, Yamamoto Y, Yoshida T,
Mizoguchi N, Nonaka T, Kubota A, Narimatsu H, Miyagi Y, Kobayashi
T, Kaneta T and Inoue T: Prognostic value of volumetric FDG PET/CT
parameters in patients with oral tongue squamous cell carcinoma who
were treated by superselective intra-arterial chemoradiotherapy.
Jpn J Radiol. 35:740–747. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chi HC, Tsai CY, Tsai MM, Yeh CT and Lin
LH: Roles of long noncoding RNAs in recurrence and metastasis of
radiotherapy-resistant cancer stem cells. Int J Mol Sci. 18(pii):
E19032017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sen Z, Zhan XK, Jing J, Yi Z and Wanqi Z:
Chemosensitizing activities of cyclotides from Clitoria ternatea in
paclitaxel-resistant lung cancer cells. Oncol Lett. 5:641–644.
2013. View Article : Google Scholar : PubMed/NCBI
|
